EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients

Simone Di Cola iD, Giulia Cusi iD, Lucia Lapenna iD, Jakub Gazda iD, Stefano Fonte iD, Marco Mattana iD, Gianluca Mennini iD, Patrizio Pasqualetti iD, Manuela Merli iD

Canadian Journal of Gastroenterology and Hepatology · 23.06.2023 · 2023 · 1-9

DOI: 10.1155/2023/2199193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, erschienen am 23.06.2023. Verfasst von Simone Di Cola und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University of Rome, Viale Dell'Università 37, Rome 00185, Italy. Hauptthemen laut MEDLINE: Liver Transplantation, Metabolic Syndrome, Diabetes Mellitus, Metabolic Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases are currently one of the most important causes of morbidity and mortality in liver transplant patients over the long term. Therefore, evaluating prognostic factors for cardiovascular events (CVEs) in this population is essential for taking preventive measures. The aim of this study was to identify the impact of diabetes and other metabolic disorders on CVEs in liver transplant patients. Three hundred fifty-six liver transplant recipients who survived at least 6 months after surgery were enrolled. Patients were followed for a median time of 118 months (12–250 months). All cardiovascular events were carefully recorded and detailed in the patients’ charts. Demographic data, diabetes, hypertension, dyslipidemia, weight changes, and a diagnosis of metabolic syndrome both before and after transplantation were noted to assess their possible relationship with CVE. The presence of a diagnosis of metabolic-associated fatty liver disease (MAFLD) was also evaluated. Immunosuppressive therapy was included in the analysis. Diabetes mellitus (DM), especially when present before transplantation, was strongly associated with CVEs (hazard risk HR 3.10; 95% confidence interval CI: 1.60–6.03). Metabolic syndrome was found to be associated with CVEs in univariate analysis (HR 3.24; 95% CI: 1.36–7.8), while pretransplantation and de novo MAFLD were not. Immunosuppressive therapy had no influence on predisposing transplanted patients to CVEs during follow-up. Further prospective studies may be useful in investigating the risk factors for CVEs after liver transplantation and improving the long-term survival of transplant patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationMetabolic SyndromeDiabetes MellitusMetabolic DiseasesCardiovascular DiseasesNon-alcoholic Fatty Liver DiseaseHumansProspective StudiesRisk Factors

Autor:innen und Institutionen

  • Department of Translational and Precision Medicine, Sapienza University of Rome, Viale Dell'Università 37, Rome 00185, Italy.
  • 2nd Department of Internal Medicine, Pavol Jozef Safarik University and Louis Pasteur University Hospital, Trieda SNP 1, Kosice 040 11, Slovakia.
  • Department of Hepato-Biliopancreatic and Transplant Surgery, Sapienza University of Rome, Viale Del Policlinico 155, Rome 00161, Italy.
  • Department of Public Health and Infectious Diseases, Faculty of Pharmacy and Medicine, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

ORCID-Profile: Simone Di Cola, Giulia Cusi, Lucia Lapenna, Jakub Gazda, Stefano Fonte, Marco Mattana, Gianluca Mennini, Patrizio Pasqualetti, Manuela Merli

Zitieren

APA

Di Cola, S., Cusi, G., Lapenna, L., Gazda, J., Fonte, S., Mattana, M., Mennini, G., Pasqualetti, P., & Merli, M. (2023). Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients. Canadian Journal of Gastroenterology and Hepatology, 2023, 1-9. https://doi.org/10.1155/2023/2199193

Vancouver

Di Cola S, Cusi G, Lapenna L, Gazda J, Fonte S, Mattana M, et al. Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients. Canadian Journal of Gastroenterology and Hepatology. 2023;2023:1-9. doi:10.1155/2023/2199193

BibTeX
@article{DiCola2023,
  author = {Di Cola, Simone and Cusi, Giulia and Lapenna, Lucia and Gazda, Jakub and Fonte, Stefano and Mattana, Marco and Mennini, Gianluca and Pasqualetti, Patrizio and Merli, Manuela},
  title = {Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients},
  journal = {Canadian Journal of Gastroenterology and Hepatology},
  year = {2023},
  volume = {2023},
  pages = {1--9},
  doi = {10.1155/2023/2199193}
}
Kostenlos starten →